These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 9918566)

  • 1. Acetyl-11-keto-beta-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I.
    Hoernlein RF; Orlikowsky T; Zehrer C; Niethammer D; Sailer ER; Simmet T; Dannecker GE; Ammon HP
    J Pharmacol Exp Ther; 1999 Feb; 288(2):613-9. PubMed ID: 9918566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A propionyloxy derivative of 11-keto-β-boswellic acid induces apoptosis in HL-60 cells mediated through topoisomerase I & II inhibition.
    Chashoo G; Singh SK; Sharma PR; Mondhe DM; Hamid A; Saxena A; Andotra SS; Shah BA; Qazi NA; Taneja SC; Saxena AK
    Chem Biol Interact; 2011 Jan; 189(1-2):60-71. PubMed ID: 21056033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic action of acetyl-11-keto-beta-boswellic acid (AKBA) on meningioma cells.
    Park YS; Lee JH; Bondar J; Harwalkar JA; Safayhi H; Golubic M
    Planta Med; 2002 May; 68(5):397-401. PubMed ID: 12058313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytostatic and apoptosis-inducing activity of boswellic acids toward malignant cell lines in vitro.
    Hostanska K; Daum G; Saller R
    Anticancer Res; 2002; 22(5):2853-62. PubMed ID: 12530009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid.
    Safayhi H; Sailer ER; Ammon HP
    Mol Pharmacol; 1995 Jun; 47(6):1212-6. PubMed ID: 7603462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of the antitumor effect of 11-keto-β-boswellic acid by its 3-α-hexanoyloxy derivative.
    Chashoo G; Singh SK; Mondhe DM; Sharma PR; Andotra SS; Shah BA; Taneja SC; Saxena AK
    Eur J Pharmacol; 2011 Oct; 668(3):390-400. PubMed ID: 21821018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
    Morgan SE; Cadena RS; Raimondi SC; Beck WT
    Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of an acetyl-11-keto-beta-boswellic acid and arachidonate-binding regulatory site of 5-lipoxygenase using photoaffinity labeling.
    Sailer ER; Schweizer S; Boden SE; Ammon HP; Safayhi H
    Eur J Biochem; 1998 Sep; 256(2):364-8. PubMed ID: 9760176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory activity of boswellic acids from Boswellia serrata against human leukemia HL-60 cells in culture.
    Shao Y; Ho CT; Chin CK; Badmaev V; Ma W; Huang MT
    Planta Med; 1998 May; 64(4):328-31. PubMed ID: 9619114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetyl-11-keto-beta-boswellic acid (AKBA) is cytotoxic for meningioma cells and inhibits phosphorylation of the extracellular-signal regulated kinase 1 and 2.
    Park YS; Lee JH; Harwalkar JA; Bondar J; Safayhi H; Golubic M
    Adv Exp Med Biol; 2002; 507():387-93. PubMed ID: 12664615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of topoisomerase IIbeta in an amsacrine-resistant human leukemia cell line with mutant topoisomerase IIalpha.
    Herzog CE; Holmes KA; Tuschong LM; Ganapathi R; Zwelling LA
    Cancer Res; 1998 Dec; 58(23):5298-300. PubMed ID: 9850052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity.
    Sailer ER; Subramanian LR; Rall B; Hoernlein RF; Ammon HP; Safayhi H
    Br J Pharmacol; 1996 Feb; 117(4):615-8. PubMed ID: 8646405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of antinociceptive effect of NSAIDs by a specific lipooxygenase inhibitor, acetyl 11-keto-beta boswellic acid.
    Bishnoi M; Patil CS; Kumar A; Kulkarni SK
    Indian J Exp Biol; 2006 Feb; 44(2):128-32. PubMed ID: 16480179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keto- and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in Hep G2 cells via a caspase-8 dependent pathway.
    Liu JJ; Nilsson A; Oredsson S; Badmaev V; Duan RD
    Int J Mol Med; 2002 Oct; 10(4):501-5. PubMed ID: 12239601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lycobetaine acts as a selective topoisomerase II beta poison and inhibits the growth of human tumour cells.
    Barthelmes HU; Niederberger E; Roth T; Schulte K; Tang WC; Boege F; Fiebig HH; Eisenbrand G; Marko D
    Br J Cancer; 2001 Nov; 85(10):1585-91. PubMed ID: 11720449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of acetyl-11-keto-β-boswellic acid on proliferation, apoptosis and cell cycle of human acute myeloid leukemia cell line HL-60].
    Yuan XY; Li YH; Qi ZH; Peng MY; Wan Z; Wang GP; Chen FP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1440-4. PubMed ID: 21176347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by boswellic acids of human leukocyte elastase.
    Safayhi H; Rall B; Sailer ER; Ammon HP
    J Pharmacol Exp Ther; 1997 Apr; 281(1):460-3. PubMed ID: 9103531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Saikosaponin-d up-regulates GR mRNA expression and induces apoptosis in HL-60 cells].
    Bu S; Xu J; Sun J
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):354-6. PubMed ID: 11721431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-Menthol inhibits DNA topoisomerases I, II alpha and beta and promotes NF-kappaB expression in human gastric cancer SNU-5 cells.
    Lin JP; Lu HF; Lee JH; Lin JG; Hsia TC; Wu LT; Chung JG
    Anticancer Res; 2005; 25(3B):2069-74. PubMed ID: 16158947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitumor mechanism of 3-bromopropionylamino benzoylurea on leukemia and lymphoma].
    Li JN; Song DQ; Jiang JD
    Yao Xue Xue Bao; 2004 Jul; 39(7):491-5. PubMed ID: 15493834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.